DK191089D0 - Biologisk aktive forbindelser - Google Patents

Biologisk aktive forbindelser

Info

Publication number
DK191089D0
DK191089D0 DK191089A DK191089A DK191089D0 DK 191089 D0 DK191089 D0 DK 191089D0 DK 191089 A DK191089 A DK 191089A DK 191089 A DK191089 A DK 191089A DK 191089 D0 DK191089 D0 DK 191089D0
Authority
DK
Denmark
Prior art keywords
biological active
relations
active relations
biological
active
Prior art date
Application number
DK191089A
Other languages
English (en)
Other versions
DK191089A (da
Inventor
Robert John Ife
David Gwyn Cooper
Robert Antony Slater
Karlheinz Stegmeier
Ernst-Christian Witte
Original Assignee
Smith Kline French Lab
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878719717A external-priority patent/GB8719717D0/en
Priority claimed from GB878725540A external-priority patent/GB8725540D0/en
Application filed by Smith Kline French Lab, Boehringer Mannheim Gmbh filed Critical Smith Kline French Lab
Publication of DK191089D0 publication Critical patent/DK191089D0/da
Publication of DK191089A publication Critical patent/DK191089A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK191089A 1987-08-20 1989-04-19 Biologisk aktive forbindelser DK191089A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB878719717A GB8719717D0 (en) 1987-08-20 1987-08-20 Pharmaceutically active compounds
GB878725540A GB8725540D0 (en) 1987-10-30 1987-10-30 Pharmaceutically active compounds
PCT/GB1988/000674 WO1989001330A2 (en) 1987-08-20 1988-08-16 W-arylsulphonamidoalkanoic acids for treatment of thromboxane mediated diseases

Publications (2)

Publication Number Publication Date
DK191089D0 true DK191089D0 (da) 1989-04-19
DK191089A DK191089A (da) 1989-04-19

Family

ID=26292628

Family Applications (1)

Application Number Title Priority Date Filing Date
DK191089A DK191089A (da) 1987-08-20 1989-04-19 Biologisk aktive forbindelser

Country Status (10)

Country Link
US (1) US4997847A (da)
EP (1) EP0304271A3 (da)
JP (1) JPH02501142A (da)
KR (1) KR890701095A (da)
CA (1) CA1331465C (da)
DK (1) DK191089A (da)
FI (1) FI891820A7 (da)
HU (1) HU208113B (da)
PT (1) PT88288B (da)
WO (1) WO1989001330A2 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3932403A1 (de) * 1989-05-12 1991-04-11 Thomae Gmbh Dr K Neue arylsulfonamide, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IL94805A (en) * 1989-06-28 1994-04-12 Ciba Geigy Ag (Arylsulfonamido- and pyridyl- or imidazolyl-)-substituted carboxylic acids, processfor their preparation and pharmaceutical compositions containing them
US5153214A (en) * 1989-06-28 1992-10-06 Ciba-Geigy Corporation Certain (arylsulfonamido- and imidazolyl-)-substituted carboxylic acids and derivatives thereof and use for suppressing thromboxane activity
US5025025A (en) * 1989-06-28 1991-06-18 Ciba-Geigy Corporation (Arylsulfonamido- and pyridyl-)-substituted carboxylic acids and derivatives thereof and use for suppressing thromboxane activity
US5474766A (en) * 1992-12-18 1995-12-12 Washington University Methods and compositions for inhibition of hepatic clearance of tissue-type plasminogen activator
GB2295389B (en) * 1994-11-25 1998-01-21 Zeneca Ltd Halogenated acids and esters useful as intermediates for insecticides
IL115833A (en) * 1994-11-25 1998-10-27 Zeneca Ltd 6,6-Dihalo-3,3-dimethyl-5-hydroxy-7,7,7-trifluoroheptanoic acids and their alkyl esters useful as intermediates for insecticides and their preparation
DE102005005397B4 (de) * 2005-02-05 2008-08-21 Lts Lohmann Therapie-Systeme Ag Isolierung von N-Butylbenzolsulfonamid, Synthese von Benzolsulfonamid-Derivaten sowie Verwendung von N-Butylbenzolsulfonamid und Benzolsulfonamid-Derivaten zur Behandlung der benignen Prostatahyperplasie und/oder des Prostatakarzinoms

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3666779A (en) * 1967-07-15 1972-05-30 Hoechst Ag Sulfonamido carboxylic acids
DE1298672B (de) * 1967-07-15 1969-07-03 Hoechst Ag Korrosionsverhinderndes Metallbearbeitungsmittel
JPS57314B2 (da) * 1974-04-10 1982-01-06
JPS5829784B2 (ja) * 1975-08-22 1983-06-24 萬有製薬株式会社 オメガ − （ アリ−ルスルホンアミド ）− アルキルアミンノ セイホウ
DE3266360D1 (en) * 1981-06-16 1985-10-24 Choay Sa Medicines containing as active ingredients compounds of the arylbenzenesulfonamide-type, and processes for their preparation

Also Published As

Publication number Publication date
EP0304271A3 (en) 1992-09-02
HU208113B (en) 1993-08-30
CA1331465C (en) 1994-08-16
WO1989001330A3 (en) 1989-05-05
PT88288A (pt) 1989-09-14
EP0304271A2 (en) 1989-02-22
WO1989001330A2 (en) 1989-02-23
JPH02501142A (ja) 1990-04-19
KR890701095A (ko) 1989-12-19
US4997847A (en) 1991-03-05
FI891820L (fi) 1989-04-17
FI891820A0 (fi) 1989-04-17
HU884709D0 (en) 1990-02-28
DK191089A (da) 1989-04-19
FI891820A7 (fi) 1989-04-17
PT88288B (pt) 1995-03-31

Similar Documents

Publication Publication Date Title
DK393888A (da) Vaskemiddel
DE3876558D1 (de) Hyposensibilisierend wirksame substanz.
DE3878989D1 (de) Brutschrank.
DK224687D0 (da) Aktive forbindelser
DK580888A (da) Mejetaersker
DK445288A (da) Forbindelser
FI88825C (fi) Aktivt pansar
BG78365A (bg) Инсектицидно средство
DK109590D0 (da) Biologisk aktivt protein
DK191089A (da) Biologisk aktive forbindelser
BR8804951A (pt) Ferradura
DK551588A (da) Parasitmiddel
FI883254A0 (fi) Cytostatiskt aktiva antracyklinderivat.
KR890700914A (ko) 멀티콘덴서 배열
DE3888440D1 (de) Optisch aktive 2-Biphenylpyridine.
FI843000L (fi) Biologisk aktiva kompositioner.
KR890701560A (ko) N-시아노메틸-2-피리디논 살충제
DK674187A (da) Aktive forbindelser
DK196588A (da) Forbinding
FI883253A0 (fi) Cytostatiskt aktiva antracyklinderivat.
KR890012275U (ko) 경운기용 배토기
DK661888D0 (da) Biologisk aktive molekyler
BR6700136U (pt) Incubadora
KR890012708U (ko) 활동완구
BR6702560U (pt) Babadouro descartavel

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment